SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-0.58%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$300M
AUM Growth
-$202M
(-40%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-70.9%
Top 10 Holdings %
Top 10 Hldgs %
37.39%
Holding
273
New
28
Increased
51
Reduced
62
Closed
72
Top Buys
| 1 |
Alkermes
ALKS
|
$10.5M |
| 2 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$6.24M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.16M |
| 4 |
United Therapeutics
UTHR
|
$5.45M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$5.01M |
Top Sells
| 1 |
Biogen
BIIB
|
$22.9M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 3 |
Viatris
VTRS
|
$15.2M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$15M |
| 5 |
Edwards Lifesciences
EW
|
$11.7M |
Sector Composition
| 1 | Healthcare | 63.58% |
| 2 | Technology | 2.74% |
| 3 | Consumer Staples | 0.59% |
| 4 | Industrials | 0.54% |
| 5 | Materials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$375B
| $2.74M | 0.15% |
46,166
+22,650
| +96% | +$1.34M |
|
|
SRNE
27
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.61M | 0.14% |
300,000
+132,936
| +80% | +$1.16M |
|
|
TTOO
28
DELISTED
T2 Biosystems, Inc
TTOO
| $2.52M | 0.14% |
46
+15
| +48% | +$822K |
|
|
OASM
29
DELISTED
Oasmia Pharmaceutical AB
OASM
| $2.4M | 0.13% |
+663,138
| New | +$2.4M |
|
|
CSCI
30
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $2.39M | 0.13% |
+5,341
| New | +$2.39M |
|
31
Benitec Biopharma
BNTC
$370M
| $2.38M | 0.13% |
2,342
+361
| +18% | +$366K |
|
|
PRTK
32
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.33M | 0.13% |
122,613
+5,567
| +5% | +$106K |
|
|
ANAC
33
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $2.26M | 0.12% |
20,000
+12,000
| +150% | +$1.36M |
|
|
MNTA
34
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.23M | 0.12% |
150,030
+100,000
| +200% | +$1.48M |
|
|
BCLI
35
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.2M | 0.12% |
51,302
-5,521
| -10% | -$237K |
|
36
Iovance Biotherapeutics
IOVA
$865M
| $2.08M | 0.11% |
270,000
-291,894
| -52% | -$2.25M |
|
|
RDHL
37
Redhill Biopharma
RDHL
$2.87M
| $2.06M | 0.11% |
160
-14
| -8% | -$181K |
|
38
Pluri
PLUR
$39.5M
| $2.05M | 0.11% |
22,658
+4,228
| +23% | +$382K |
|
39
Lipocine
LPCN
$15.7M
| $1.97M | 0.11% |
8,954
-2,894
| -24% | -$636K |
|
40
Regenxbio
RGNX
$493M
| $1.94M | 0.11% |
+116,860
| New | +$1.94M |
|
|
FOMX
41
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.93M | 0.11% |
238,400
-4,961
| -2% | -$40.2K |
|
42
Adverum Biotechnologies
ADVM
$71.8M
| $1.86M | 0.1% |
19,513
-37,913
| -66% | -$3.61M |
|
|
ACUR
43
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $1.84M | 0.1% |
727,865
-15,738
| -2% | -$39.8K |
|
|
RGLS
44
DELISTED
Regulus Therapeutics
RGLS
| $1.83M | 0.1% |
1,750
-1,221
| -41% | -$1.28M |
|
45
Galectin Therapeutics
GALT
$293M
| $1.78M | 0.1% |
+1,086,615
| New | +$1.78M |
|
|
RIBT
46
DELISTED
RiceBran Technologies
RIBT
| $1.77M | 0.1% |
93,344
+3,147
| +3% | +$59.8K |
|
|
LJPC
47
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.76M | 0.1% |
65,158
-19,853
| -23% | -$536K |
|
48
BioCryst Pharmaceuticals
BCRX
$1.73B
| $1.71M | 0.09% |
165,529
+79,134
| +92% | +$817K |
|
|
DBVT
49
DBV Technologies
DBVT
$245M
| $1.69M | 0.09% |
4,659
+2,805
| +151% | +$1.02M |
|
50
MediciNova
MNOV
$66.7M
| $1.69M | 0.09% |
474,803
-25,197
| -5% | -$89.5K |
|